Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Accumulated Expenses (2016 - 2025)

National Research (NRC) has disclosed Accumulated Expenses for 16 consecutive years, with $2.9 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 39.32% to $2.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.9 million through Dec 2025, down 39.32% year-over-year, with the annual reading at $2.9 million for FY2025, 39.32% down from the prior year.
  • Accumulated Expenses hit $2.9 million in Q4 2025 for National Research, down from $7.1 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $7.1 million in Q4 2021 to a low of $2.9 million in Q4 2025.
  • Historically, Accumulated Expenses has averaged $5.2 million across 5 years, with a median of $5.1 million in 2024.
  • Biggest five-year swings in Accumulated Expenses: surged 89.68% in 2022 and later crashed 39.32% in 2025.
  • Year by year, Accumulated Expenses stood at $7.1 million in 2021, then plummeted by 36.25% to $4.6 million in 2022, then fell by 13.14% to $4.0 million in 2023, then rose by 20.77% to $4.8 million in 2024, then plummeted by 39.32% to $2.9 million in 2025.
  • Business Quant data shows Accumulated Expenses for NRC at $2.9 million in Q4 2025, $7.1 million in Q3 2025, and $5.6 million in Q2 2025.